Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Journal of the Neurological Sciences
|
September 23, 2008
New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity
Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Nature Medicine
|
May 23, 2006
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells
Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Journal of Neuroinflammation
|
July 26, 2023
Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
Dorit Farfara, Meital Sooliman, Limor Avrahami, et al.
The Journal of Clinical Investigation
|
March 15, 2008
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
Alexandre S Basso, Dan Frenkel, Francisco J Quintana, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2004
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway
Jaime Imitola, Khadir Raddassi, Kook In Park, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 9, 2021
From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment
Yuval Nash, Assaf Ganoth, Nofit Borenstein-Auerbach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
Homocysteine fibrillar assemblies display cross-talk with Alzheimer's disease β-amyloid polypeptide
Dorin Sade Yazdi, Dana Laor Bar-Yosef, Hanaa Adsi, et al.
Npj Aging
|
June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trial
Panayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk
Roger B Dodd, Masahiro Enomoto, Ye Zhou, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Journal of the Neurological Sciences
|
September 23, 2008
New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity
Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Nature Medicine
|
May 23, 2006
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells
Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Journal of Neuroinflammation
|
July 26, 2023
Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
Dorit Farfara, Meital Sooliman, Limor Avrahami, et al.
The Journal of Clinical Investigation
|
March 15, 2008
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
Alexandre S Basso, Dan Frenkel, Francisco J Quintana, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2004
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway
Jaime Imitola, Khadir Raddassi, Kook In Park, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 9, 2021
From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment
Yuval Nash, Assaf Ganoth, Nofit Borenstein-Auerbach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
Homocysteine fibrillar assemblies display cross-talk with Alzheimer's disease β-amyloid polypeptide
Dorin Sade Yazdi, Dana Laor Bar-Yosef, Hanaa Adsi, et al.
Npj Aging
|
June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trial
Panayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk
Roger B Dodd, Masahiro Enomoto, Ye Zhou, et al.
Page
of 7